市场调查报告书
商品编码
1198535
手术单和手术服市场 - 增长、趋势、COVID-19 影响和预测 (2023-2028)Surgical Drapes and Gowns Market- Growth, Trends, and Forecasts (2023 - 2028) |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计在预测期内(2022 年至 2027 年)手术单和手术服市场的复合年增长率为 5.6%。
全球经济的几乎每个方面,包括全球供应链,都受到 COVID-19 大流行的严重打击。 最初,工厂停工,生产放缓,一些国家的进出口受到限制,运输减慢或停止。 埃博拉、乙型肝炎、丙型肝炎、SARS 和最近的 COVID-19 爆发提高了全球对个人防护装备 (PPE) 的认识。 自 COVID-19 爆发以来,对外科口罩、手套和防护服等个人防护装备 (PPE) 的需求猛增。 市场参与者也在努力满足对手术服、手术单等不断增长的需求。 例如,2020 年 10 月,Health Supply US (HSUS) 向美国国防后勤局 (DLA) 交付了 100% 美国製造的隔离服。 HSUS 致力于生产多达 3500 万件符合贝瑞修正案的礼服,以通过其国家战略储备为国家应对 COVID-19大流行做出贡献。 因此,COVID-19 对市场增长产生了重大影响。
由于运动损伤、事故、心血管疾病和其他慢性疾病的高发率,越来越多涉及心臟手术的外科手术被认为是强制性的。这是推动手术单和手术服市场的主要因素。 由于对患者和医护人员保护的需求不断增长以及手术部位感染的流行率不断上升,因此对手术衣和手术单的需求量很大。 根据 2020 年年度国家和州 HAI 进展报告,2020 年美国急症医院报告的成人手术部位感染约为 18,416 例,儿童约为 464 例。 许多传染病正在创造对手术服和手术单的需求,这有望推动市场增长。
此外,市场参与者采取的战略举措也在推动市场的增长。 例如,2021 年 12 月,Medline 和 3M 合作标准化了热外科手术服。 所有患者的常温护理标准可减少术后手术部位感染 (SSI) 和并发症。 这种合作通过进步提高创新和采用率,从而推动市场增长。
然而,可重复使用的手术服和手术服引起的感染和产品召回是限製手术手术服和手术服市场增长的主要因素。
手术服是医疗环境中使用的个人防护装备的一个例子。 根据在医院的用途,它们被称为手术衣、隔离衣、手术隔离衣、手术衣、手术室衣等。
COVID-19 大流行对细分市场产生了重大影响。 根据 2020 年 12 月题为“COVID-19-PPE 需求和供应前景”的报告,行业专家表示,由于 COVID-19 大流行,全球医用 PPE 产量在高峰期至少增加了 300%。 这种增加将在 2020 年第一季度末/第二季度初开始,以弥补全球短缺并满足来自政府和私营实体的前瞻性激增订单。 国际现有企业扩大产能占供应增长的 50-60%。 例如,杜邦将礼服的产量翻了一番。
此外,在医疗保健领域,医务人员无需帮助即可自行穿上的可自行拆卸手术服的需求不断增长。 此外,在慢性病毒和传染病危机管理中,使用可快速安全脱下的防护服比以往任何时候都更重要,以防止环境感染的传播。 此外,市场参与者增加的投资也推动了该行业的增长。 例如,2021 年 5 月,总部位于温莎的 Harbor Technologies 扩大了其防护装备製造业务,在查塔姆肯特开设了一家最先进的製造工厂,生产手术隔离服。
因此,由于上述因素,该细分市场有望在预测期内呈现增长。
北美占据了很大的市场份额,预计在预测期内将保持不变。
美国食品药品监督管理局 (FDA) 于 2020 年 3 月宣布,随着美国 COVID-19 病例数量的增加以及医院努力确保医生和护士的安全,某些个人物品(例如防护服和手套)宣布了指南概述放宽某些监管要求以增加个人防护设备 (PPE) 的生产和可用性。 因此,自 COVID-19 大流行开始以来,美国的 PPE 製造业有了显着改善。 来自各行各业的选手也参与了这次的传染病对策。 由于 COVID-19,总部位于北温哥华的 Arc'teryx 已将其部分产能转移到为当地医院的一线工作人员生产急需的手术服。确实如此。
此外,由于成熟市场参与者的存在、外科手术数量的增加以及手术部位感染的增加,北美在全球手术单和手术服市场占据主导地位。 例如,根据 2021 年 12 月在美国国家医学图书馆发表的题为“术后伤口感染”的论文,美国住院患者中有超过 200 万例院内感染是由手术部位伤口感染引起的……显然。 ..
此外,2020年9月,Halyard Health投资约2600万美元扩大其手套、手术衣等个人防护设备的製造业务。 此类投资将增加该地区手术服的产量,从而推动市场增长。
因此,由于上述因素,预计北美地区在预测期内将出现增长。
手术单和手术服市场竞争激烈,大多数参与者都在争相增加市场份额。 市场参与者包括 3M、Cardinal Health、Medline Industries, Inc、Sterisets International BV、Owens & Minor (Halyard)、Surgeine Healthcare、Medica Europe BV、Molnlycke Health Care AB、Primewear、Amaryllis Healthcare Private Limited、Rysley Limited、Sterimed Group , Thermo Fisher Scientific Inc. 等
The surgical drapes and gowns market is projected to register a CAGR of 5.6% during the forecast period (2022-2027).
Almost every aspect of the global economy, including the global supply chain, was severely disrupted by the COVID-19 pandemic. Initially, factories were shut down or slowed production; several countries imposed export and import restrictions, and transportation was slowed or halted. Emerging diseases such as Ebola hemorrhagic fever, hepatitis B, hepatitis C, SARS, and, most recently, the COVID-19 epidemic have raised awareness for personal protective equipment (PPE) worldwide. Since the start of the COVID-19 pandemic, demand for personal protective equipment (PPE) such as surgical masks, gloves, and gowns were skyrocketed. The market players were also taking initiatives to meet the increasing demand for surgical gowns, drapes, and others. For instance, in October 2020, Health Supply US (HSUS) delivered 100% American-made isolation gowns to the United States Defense Logistics Agency (DLA). HSUS was working to produce up to 35 million Berry Amendment-compliant gowns that will contribute to the nation's response to the COVID-19 pandemic through the Strategic National Stockpile. Thus, COVID-19 has significantly impacted the growth of the market.
The growing number of surgical procedures due to sports injuries, accidents, and cardiac surgeries owing to the high prevalence of cardiovascular diseases and other chronic conditions where surgery is being suggested as mandatory is the primary factor driving the surgical drapes and gowns market. Surgical gowns and drapes are also in high demand due to the rising demand for patient and healthcare worker protection and the increasing prevalence of surgical site infections. According to the Annual National and State HAI Progress Report, 2020, there were about 18,416 surgical site infections reported in adults, and 464 surgical site infections were recorded in a pediatric population from acute care hospitals in the United States in 2020. A large number of infections creates the need for surgical gowns and drapes and is thus expected to propel the growth of the market.
Additionally, the strategic initiatives undertaken by the market players are also propelling the growth of the market. For instance, in December 2021, Medline and 3M collaborated to standardize surgical warming gowns. Creating a normothermia standard of care for every patient reduces post-operative surgical site infections (SSIs) and complications. Such collaborations increase innovation and adoption rates due to their advancements, thus driving the market's growth.
However, infections due to reusable gowns and drapes and product recalls are the major restraints on the growth of the surgical drapes and gowns market.
A surgical gown is one example of personal protective equipment used in healthcare settings. Different names are given to them according to their intended use in hospitals, such as surgical gowns, isolation gowns, surgical isolation gowns, procedural gowns, and operating room gowns, among others.
The COVID-19 pandemic has had a significant impact on the market segment. As per the December 2020 report titled "COVID-19 - PPE demand & supply perspectives", industry experts stated that global production of medical PPE increased by at least 300% at its peak as a result of the COVID-19 pandemic. This ramp-up began in late Q1/early Q2 of 2020 to compensate for a global shortage and meet forward-looking surge orders from governments and private entities. Existing international players expanding their production capacities accounted for 50% to 60% of the increase in supply. For instance, DuPont doubled its gown output.
Moreover, in the healthcare setting, there is a growing demand for a self-donning surgical gown that healthcare personnel can don without assistance. Also, in the context of crisis management during chronic viral and infectious diseases, using a gown that can be put on and removed quickly and safely to prevent onward transmission of environmental infection is more important than ever. Additionally, the increasing investment by the market players is also propelling the growth of the segment. For instance, in May 2021, Windsor-based Harbour Technologies expanded its protective equipment manufacturing operations to Chatham-Kent by opening a state-of-the-art manufacturing facility in Chatham to make surgical isolation gowns.
Thus, owing to the abovementioned factors, the market segment is expected to show growth over the forecast period.
North America is expected to hold a significant share in the market and is expected to do the same over the forecast period.
The Food and Drug Administration (FDA) released guidance in March 2020 explaining the relaxation of specific regulatory requirements to increase the production and availability of certain personal protective equipment (PPE) such as gowns and gloves as the number of COVID-19 cases grew in the United States and hospitals struggled to keep their doctors and nurses safe. As a result, PPE manufacturing in the United States has greatly improved since the onset of the COVID-19 pandemic. Various players from different verticals joined to combat the infection as well. Due to COVID-19, Arc'teryx, based in North Vancouver, shifted some of its production capacity to create urgently needed surgical gowns for front-line workers in local hospitals.
Moreover, North America dominated the global surgical drapes and gowns market owing to the presence of well-established market players, a growing number of surgical procedures, and an increasing number of surgical site infections. For instance, as per the article titled "Postoperative Wound Infection" published in December 2021 in the National Library of Medicine, over two million nosocomial infections in individuals who have been hospitalized in the United States are caused by surgical site wound infections.
Additionally, in September 2020, Halyard Health invested around USD 26 million to expand personal protective equipment, including gloves, surgical gowns, and other manufacturing operations. With such investments, there will be increased production of surgical gowns in the region, which will drive market growth.
Thus, owing to the abovementioned factors, the North American region is expected to show growth over the forecast period.
The surgical drapes and gowns market is very competitive, with most players competing to increase market share. Some of the players operating in the market are 3M, Cardinal Health, Medline Industries, Inc., Sterisets International BV, Owens & Minor (Halyard), Surgeine Healthcare, Medica Europe BV, Molnlycke Health Care AB, Primewear, Amaryllis Healthcare Private Limited, Rhysley Limited, Sterimed Group, and Thermo Fisher Scientific Inc.